학술논문
P-133 Clinical responses in pancreaticobiliary cancer patients who received bintrafusp alfa (BA) or BA plus CXCR1/2 inhibitor (SX-682) plus CEA/MUC1-targted vaccine (CV301)
Document Type
Abstract
Author
Source
In Annals of Oncology June 2022 33 Supplement 4:S297-S297
Subject
Language
ISSN
0923-7534